AI assistant
Sending…
DAVITA INC. — Director's Dealing 2013
Apr 3, 2013
30643_dirs_2013-04-03_fc5ef707-ddd7-42de-b331-194d86ccbaab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2013-04-03
Reporting Person: Valine Roger (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-04-03 | Common Stock | M | 4500 | $82.93 | Acquired | 11713 | Direct |
| 2013-04-03 | Common Stock | F | 2934 | $127.20 | Disposed | 8779 | Direct |
| 2013-04-03 | Common Stock | S | 1566 | $126.97 | Disposed | 7213 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-04-03 | Stock Appreciation Right | $82.93 | M | 4500 | Disposed | 2016-06-06 | Common Stock (4500) | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/10/2012.
F2: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 100% on the first anniversary of the grant date.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25